Tag: PCK

PainChek aged care beds March 2020 ASX PCK

Residential aged care sector drives strong quarterly results for PainChek

Australian medical device company PainChek (ASX: PCK) has reported a strong performance for the March quarter with much of its growth being driven by the country’s residential aged care sector. Pai...
PainChek dementia bed licenses ASX PCK Federal Government Australia

PainChek grows number of licenced beds, triggers $1.25 million payment from federal government

Medical device company PainChek (ASX: PCK) confirmed it has met an important 25,000 licensed bed milestone under a $5 million grant agreement with the Australian federal government. In total, PainChe...
Painchek ASX PCK smartphone app UK aged care

PainChek expands UK presence with first orders of pain assessment technology

Australian medical device company PainChek (ASX: PCK) is expanding its presence in the UK market, making its first direct sale and confirming first orders for the region. PainChek has developed a s...
PainChek ASX PCK Australian pain assessment software technology residential aged care Ward Medication Management Ward MM

PainChek prepares for Australian rollout of pain assessment software in residential aged care

Healthcare innovator PainChek (ASX: PCK) has announced that it intends to partner up with Ward Medication Management (Ward MM) to deliver a state-funded national roll-out of its pain assessment techno...
PainChek ASX PCK Allium Healthcare Singapore dementia

PainChek gets Singapore regulatory clearance, signs landmark deal with nation’s leading aged care provider

Australian medical device company PainChek (ASX: PCK) has advanced its international expansion strategy with receipt of a key regulatory clearance from Singapore’s Health Sciences Authority and the su...
PainChek ASX PCK Murdoch Children’s Research Institute trial pain app infants

PainChek partners with Australia’s largest child health research institute to trial pain app in infants

As part of its plan to expand its PainChek app to children worldwide, PainChek (ASX: PCK) has teamed up with the Melbourne Murdoch Children’s Research Institute to clinically test a version of the app...
Painchek ASX PCK UK market Person Centred Software

PainChek expands internationally with Person Centred Software UK distribution agreement

PainChek (ASX: PCK) has secured a binding distribution agreement with Person Centred Software paving the way for the company to launch its pain assessment and monitoring technology into international ...
Federal Government PainChek Australia ASX PCK grant dementia app

Federal Government to invest $5m in PainChek’s app for dementia patients

Australian medical device company PainChek (ASX: PCK) is set to receive a $5 million grant from the Australian Federal Government to trial its pain recognition and monitoring technology in the country...
PainChek ASX PCK Churches of Christ in Queensland residential aged care

PainChek signs licence agreement with Queensland aged care provider

Digital health company PainChek (ASX: PCK) has executed a licence agreement with Churches Of Christ in Queensland, which will give the aged care provider the ability to deploy the monitoring technolog...
PainChek ASX PCK ePAT peer-reviewed study

PainChek receives ePAT validation in peer-reviewed study

PainChek’s (ASX: PCK) proprietary pain-detection product has been officially validated by a peer-reviewed study and in added support towards its overall clinical usefulness in detecting pain amongst n...
PainChek ASX PCK app detects pain AI analyse facial micro-expressions

PainChek to secure FDA De Novo classification

Formerly ePat Technologies (ASX: EPT), medical device company PainChek (ASX: PCK) is on course to secure De Novo classification from the Food and Drug Administration (FDA) in the US ­— a relatively ne...